SUICIDALITY in the perinatal period: comparison of two self-report instruments. Results from PND-ReScU

The aim of this study was to assess suicidality in a non-clinical sample during the perinatal period and to report suicidality
rates in women with major or minor depressive episode (MmD), assessed with the SCID, during the perinatal period. Women (1,066) were recruited at the third month of pregnancy and followed until the 12th month postpartum (N = 500). Suicidality was assessed with the MOODS-SR and with item 10 of the EPDS at different time-points during the perinatal
period. The period prevalence of suicidality was 6.9% (95% CI: 6.0–7.8) during pregnancy and 4.3% (95% CI: 3.4–5.2) during
postpartum, assessed with the MOODS-SR, and was 12.0% (95% CI: 10.8–13.2) during pregnancy and 8.6% (95% CI: 7.4–9.8) during
the postpartum period, assessed with the EPDS. The prevalence of suicidality in women who had MmD during pregnancy was 26.4%
and 34.1%, assessed with the MOODS-SR and the EPDS, respectively, while it was 18.4% (MOODS-SR) and 30.6% (EPDS) during the
postpartum period. Clinicians should assess suicidality in women presenting with MmD during the whole perinatal period. Furthermore,
suicidality should be assessed in women with a previous history of psychiatric disorder that reported a lifetime suicidal
ideation.